Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) has received an average recommendation of “Moderate Buy” from the thirty-one research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and twenty-two have given a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $508.68.
A number of brokerages have commented on ISRG. Bank of America dropped their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. JPMorgan Chase & Co. reduced their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a report on Friday, July 17th. Raymond James Financial reaffirmed an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th.
Check Out Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Trading Up 1.4%
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter last year, the firm posted $1.81 EPS. The firm’s revenue was up 18.4% compared to the same quarter last year. Analysts predict that Intuitive Surgical will post 8.87 earnings per share for the current year.
Insider Activity at Intuitive Surgical
In other news, Director Amy L. Ladd sold 72 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the transaction, the director directly owned 179 shares of the company’s stock, valued at approximately $70,364.90. The trade was a 28.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the sale, the director directly owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock valued at $4,891,989 over the last 90 days. Insiders own 0.60% of the company’s stock.
Hedge Funds Weigh In On Intuitive Surgical
Large investors have recently added to or reduced their stakes in the company. Main Street Group LTD purchased a new position in shares of Intuitive Surgical in the 1st quarter worth approximately $30,000. Compass Financial Management LLC purchased a new stake in Intuitive Surgical during the second quarter valued at approximately $30,000. Vermillion Wealth Management Inc. lifted its position in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares during the last quarter. Motiv8 Investments LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $34,000. Finally, Evergreen Advisors LLC purchased a new position in Intuitive Surgical in the first quarter worth $35,000. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.
The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
